Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning Improves Survival in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

被引：0
|
作者：
Khouri, Issa F. [1 ]
Saliba, Rima M. [1 ]
Ledesma, Celina [1 ]
Jabbour, Elias J. [2 ]
Turturro, Francesco [3 ]
Alatrash, Gheath [4 ]
Ahmed, Sairah [1 ]
Oran, Betul [1 ]
Patel, Krina K. [1 ]
Olson, Amanda [4 ]
Marin, David [1 ]
Popat, Uday R. [1 ]
Suki, Tina S. [1 ]
Jorgensen, Jeffrey L. [5 ]
Medeiros, L. Jeffrey [5 ]
Gulbis, Alison M. [6 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA
[6] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF IDELALISIB IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN PORTUGAL
    Silva, M. G.
    Gouveia, M.
    Alarcao, J.
    Fiorentino, F.
    Carda, J.
    Costa, R. M.
    Mariz, J. M.
    Raposo, J.
    Borges, M.
    HAEMATOLOGICA, 2015, 100 : 577 - 577
  • [42] Rituximab and Campath-1H combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL).
    Nabhan, C
    Patton, D
    Gordon, LI
    Riley, MB
    Kuzel, T
    Tallman, MS
    Rosen, ST
    BLOOD, 2003, 102 (11) : 361B - 361B
  • [43] Cost-Effectiveness of Venetoclax and Rituximab Combination Therapy in Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) in Argentina
    Elgart, Jorge Federico
    Glancszpigel, Mariana
    Kanevsky, Diego
    Godar, Maria
    Touliet, Valeria
    Albaytero, Natalia
    BLOOD, 2019, 134
  • [44] Pentostatin, Alemtuzumab, and Low Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL)
    Zent, Clive S.
    LaPlant, Betsy R.
    Link, Brian K.
    Call, Timothy G.
    Shanafelt, Tait D.
    Bowen, Deborah A.
    Kay, Neil
    Weiner, George J.
    Witzig, Thomas E.
    BLOOD, 2011, 118 (21) : 781 - 781
  • [45] COST-EFFECTIVENESS OF IDELALISIB IN COMBINATION WITH RITUXIMAB FOR THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) IN PORTUGAL
    Gouveia, M.
    Silva, M. G.
    Alarcao, J.
    Fiorentino, F.
    Carda, J.
    Costa, R.
    Mariz, J. M.
    Raposo, J.
    Costa, J.
    Borges, M.
    VALUE IN HEALTH, 2015, 18 (07) : A461 - A462
  • [46] BENDAMUSTINE (B) IN COMBINATION WITH RITUXIMAB (R) FOR PATIENTS WITH RELAPSED/RESISTANT CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): AN ITALIAN MULTICENTRE RETROSPECTIVE STUDY
    Iannitto, E.
    Morabito, F.
    Mancuso, S.
    Gentile, M.
    Augello, A.
    Bongarzoni, V.
    Cascavilla, N.
    D'Arco, A.
    Di Renzo, N.
    Fazzi, R.
    Ferrara, F.
    Franco, G.
    Gobbi, M.
    Liardo, E.
    Liberati, A. M.
    Marasca, R.
    Montanini, A.
    Mule, A.
    Musso, M.
    Musto, P.
    Pennese, E.
    Piccin, A.
    Scalabrini, D. Rota
    Sciacca, M.
    Visani, G.
    Abbadessa, V.
    Rigacci, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 323 - 323
  • [47] Combination fludarabine, cyclophosphamide and rituximab for previously treated patients with chronic lymphocytic leukemia (CLL).
    Garcia-Manero, G
    O'Brien, S
    Cortes, J
    Giles, F
    Faderl, S
    Lerner, S
    Albitar, M
    Kantarjian, HM
    Keating, MJ
    BLOOD, 2000, 96 (11) : 757A - 757A
  • [48] Outpatient-based therapy with oral fludarabine and alemtuzumab for Asian patients with relapsed/refractory chronic lymphocytic leukemia (CLL).
    Hwang, William
    Dearden, C.
    Loh, S. M.
    Linn, Y. C.
    Tien, S. L.
    Teoh, G.
    Lim, L. F.
    Liew, P. X.
    How, G. F.
    Heng, K. K.
    Goh, Y. T.
    Lee, L. H.
    BLOOD, 2006, 108 (11) : 336B - 337B
  • [49] Nonmyeloablative hematopoietic cell transplantation (HCT) for treatment of patients (pts) with fludarabine-refractory chronic lymphocytic leukemia (CLL) results in prolonged median survival.
    Sorror, M.
    Sandmaier, B.
    Maris, M.
    Storer, B.
    Radich, J.
    Agura, E.
    Niederwieser, D.
    Blume, K.
    Storb, R.
    Maloney, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 342S - 342S
  • [50] Combination of bendamustine and rituximab as salvage therapy for patients with relapsed or refractory chronic lymphocytic leukemia: Experience of single center in Russia
    Semochkin, S.
    Ivanova, V. L.
    Lukina, A. I.
    Mukha, L. A.
    Arshanskaya, E. G.
    Lazarev, I. E.
    Kulikova, S. S.
    Pochtar, M. E.
    Huazheva, N. K.
    Markaryan, V. G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S853 - S853
12345